Delivery Order SPE2DB22D2103-SPE2DB24FR9KW
Award Date 5/31/24
Potential Completion Date 6/24/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,518.40 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract, which has a ceiling value of $3,518.40 and a completion date of May 24, 2024, is for the provision of the pharmaceutical product NUBEQA 300 MG TABLET 120S. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the federal government, with a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA 300 MG TABLET 120S. The $9,367.94 firm-fixed-price contract has a completion date of September 24, 2024. Amerisourcebergen, which has significant federal contract experience, is not operating under a set-aside designation for this award. The company holds several large Indefinite Delivery Contracts (IDCs) with DLA Troop Support...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,518.40, is for the provision of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA 300 MG TABLET 120S. The contract has a firm fixed price of $14,051.91 and a period of performance through December 4, 2024. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA 300 MG TABLET 120S. The contract has a ceiling value of $7,641.98 and a completion date of July 10, 2025. It is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a $15,283.96 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a performance period through June 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,555.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. This contract is for the provision of 120 tablets of the drug NUBEQA 300 MG, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,641.98 for the supply of NUBEQA 300 MG TABLET 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 31, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency issued a $3,836.00 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for NUBEQA 300 mg tablets (120-count). The order is a call against the company's IDC with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 2026 that supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR9KWDelivery Order
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide NUBEQA 300 MG TABLET 120S, a pharmaceutical product, for $10,555.20. This Firm Fixed Price contract has a completion date of June 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. The contract does not have a set-aside designation.
Generated 8/30/24, 7:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 5/31/24 |